Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Investments (2011 - 2021)

Lifecore Biomedical, Inc. \De\'s Long-Term Investments history runs 11 years deep, the most recent figure standing at $44.8 million for Q2 2021.

• In Q2 2021, Long-Term Investments fell 21.32% year-over-year to $44.8 million; the TTM figure through May 2021 stood at $44.8 million (down 21.32% YoY), while the FY2021 annual figure was $44.8 million, down 21.32% from the prior year.
• Long-Term Investments for Q2 2021 stood at $44.8 million, down from $45.1 million in the prior quarter.
• The five-year high for Long-Term Investments was $68.1 million in Q4 2018, with the low at $44.8 million in Q2 2021.
• The 5-year median for Long-Term Investments is $62.4 million (2017), against an average of $60.3 million.
• The sharpest annual moves came in 2017 and 2020: Long-Term Investments climbed 4.94% in 2017, then declined 26.43% in 2020.
• Lifecore Biomedical, Inc. \De\'s Long-Term Investments stood at $65.8 million in 2017, then rose by 3.5% to $68.1 million in 2018, then declined by 9.99% to $61.3 million in 2019, then slipped by 26.43% to $45.1 million in 2020, then decreased by 0.73% to $44.8 million in 2021.
• Business Quant data shows LFCR's Long-Term Investments at $44.8 million in Q2 2021, $45.1 million in Q1 2021, and $45.1 million in Q4 2020.